AbbVie Inc ABBV Former Senior Immunology RD Leader Anthony Slavin Appointed SVP of Portfolio Strategy at Infinimmune Micron Technology MU Earns New Buy Initiation From Melius Research Amid Broader Wall Street Analyst Rating Shifts Vertex Pharmaceuticals VRTX ShortTerm Price Pullback Amid Broad Market Gains Presents LongTerm Entry Opportunity